Condition
Subacute Thyroiditis
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
P 2 (1)
P 3 (1)
P 4 (1)
Trial Status
Completed3
Not Yet Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07571681Phase 2Not Yet Recruiting
Colchicine for Autoimmune and Subacute Thyroiditis
NCT06391515CompletedPrimary
Subacute Thyroiditis in the SARS-CoV-2 Era
NCT06285617Phase 3Not Yet RecruitingPrimary
Short-Term Versus 6-Week Prednisone in The Treatment of Subacute Thyroiditis
NCT05070091Completed
The Impact of Pituitary-thyroid and Pituitary-adrenal Axes Function on COVID-19 Clinical Course.
NCT01837433Phase 4CompletedPrimary
Short-term Prednisone to Treat STA Study(SPTSS)
Showing all 5 trials